Slide from Katherine Tuttles presentation, during FLOW session, 61st European Renal Association Congress Conclusion The FLOW trial showed that semaglutide significantly decreased the risk of progression of kidney disease in T2DM, without significant increases in serious adverse events
When combined with a healthy diet and regular exercise, it helps users achieve significant weight loss
Clin Endocrinol (2012) 77:27580
As a skincare ingredient, it is revered for its ability to brighten and enhance the overall appearance of the skin
However, skin brightening treatments should always be approached with realistic expectations
Surgical resection of visible disease can be accomplished by excision, fulguration, and ablation techniques